Related references
Note: Only part of the references are listed.Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review
Joseph P. Schacht et al.
ADDICTION BIOLOGY (2013)
The effects of varenicline on stress-induced and cue-induced craving for cigarettes
Lara A. Ray et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence
Jennifer G. Plebani et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
Raye Z. Litten et al.
JOURNAL OF ADDICTION MEDICINE (2013)
Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: A bold FMRI study
Scott E. Lukas et al.
NEUROIMAGE (2013)
Interacting Effects of Naltrexone and OPRM I and DAT I Variation on the Neural Response to Alcohol Cues
Joseph P. Schacht et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Effects of Short-Term Varenicline Administration on Emotional and Cognitive Processing in Healthy, Non-Smoking Adults: A Randomized, Double-Blind, Study
Roel J. T. Mocking et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics
Joseph P. Schacht et al.
PSYCHOPHARMACOLOGY (2013)
Varenicline Potentiates Alcohol-Induced Negative Subjective Responses and Offsets Impaired Eye Movements
Emma Childs et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
A Single Administration of Low-Dose Varenicline Saturates α4β2* Nicotinic Acetylcholine Receptors in the Human Brain
Shahrdad Lotfipour et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Varenicline decreases alcohol consumption in heavy-drinking smokers
Jennifer M. Mitchell et al.
PSYCHOPHARMACOLOGY (2012)
Effects of Varenicline on Smoking Cue-Triggered Neural and Craving Responses
Teresa Franklin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Stability of fMRI striatal response to alcohol cues: A hierarchical linear modeling approach
Joseph P. Schacht et al.
NEUROIMAGE (2011)
Identifying Neurobiological Phenotypes Associated with Alcohol Use Disorder Severity
Eric D. Claus et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Addiction: Beyond dopamine reward circuitry
Nora D. Volkow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control
Jelte A. Wouda et al.
PSYCHOPHARMACOLOGY (2011)
A preliminary investigation of varenicline for heavy drinking smokers
Lisa M. Fucito et al.
PSYCHOPHARMACOLOGY (2011)
Retraining Automatic Action Tendencies Changes Alcoholic Patients' Approach Bias for Alcohol and Improves Treatment Outcome
Reinout W. Wiers et al.
PSYCHOLOGICAL SCIENCE (2011)
The Nicotinic Acetylcholine Receptor Partial Agonist Varenicline Increases the Ataxic and Sedative-Hypnotic Effects of Acute Ethanol Administration in C57BL/6J Mice
Helen M. Kamens et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
Effects of the α4β2 Partial Agonist Varenicline on Brain Activity and Working Memory in Abstinent Smokers
James Loughead et al.
BIOLOGICAL PSYCHIATRY (2010)
The Effect of Aripiprazole on Cue-Induced Brain Activation and Drinking Parameters in Alcoholics
Hugh Myrick et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice
Helen M. Kamens et al.
PSYCHOPHARMACOLOGY (2010)
Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
Sherry A. McKee et al.
BIOLOGICAL PSYCHIATRY (2009)
Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people
Hugh Myrick et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry
Francesca M. Filbey et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement
Nora D. Volkow et al.
JOURNAL OF NEUROSCIENCE (2007)
Varenicline, an α402 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
Pia Steensland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
H. Rollema et al.
NEUROPHARMACOLOGY (2007)
Blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI
Derik Hermann et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology
ML Kringelbach et al.
PROGRESS IN NEUROBIOLOGY (2004)
Differential brain activity in alcoholics and social drinkers to alcohol cues: Relationship to craving
H Myrick et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Advances in functional and structural MR image analysis and implementation as FSL
SM Smith et al.
NEUROIMAGE (2004)
Assessment of substance cue reactivity: Advances in reliability, specificity, and validity
WGK Stritzke et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2004)
Role of dopamine in the behavioural actions of nicotine related to addiction
G Di Chiara
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
